Study of Enhanced Recovery After Surgery Program Effects on Outcomes Following Pancreatic Cancer Surgery in Two Greek Centers

What this Trial Is About

Researchers are evaluating whether patients with pancreatic cancer who undergo surgery have better outcomes when cared for using a multidisciplinary approach called an enhanced recovery after surgery ERAS program. This study compares patients treated before and after the programs implementation to understand its effect on recovery and health after surgery. Patients having elective pancreatic surgery are managed either with traditional perioperative care or following a standardized ERAS protocol involving 20 different care elements before, during, and after surgery. The study includes two groups a control group treated with standard care and an ERAS group receiving the enhanced recovery program, both observed at two high-volume referral centers. Participants are followed to assess their length of hospital stay within 30 days after surgery, along with monitoring 30-day mortality and overall complications. Data are collected prospectively for the ERAS group and retrospectively for the control group. The study aims to measure how these care approaches impact recovery and short-term outcomes after pancreas surgery.

Effect of an Enhanced Recovery After Surgery Program on Outcomes After Pancreatoduodenectomy